Geron Corporation presented new data on imetelstat, a treatment for lower-risk myelodysplastic syndromes (LR-MDS), at key hematology conferences in Japan and Europe. The presentations included real-world evidence from U.S. patients and clinical trial results from the Phase 3 IMerge study, showing durable clinical outcomes and manageable safety. Findings suggest imetelstat may improve patient health by targeting disease biology and that early treatment-related cytopenias could predict better responses. Geron plans to expand awareness and access to imetelstat globally, supporting its use in LR-MDS and ongoing research in other blood cancers.
Geron Corporation's presentations on imetelstat at international hematology congresses provide context for health sector interest. For readers following health stocks, here is Pluang's market snapshot as of Oct 12, 2026 18:51 WIB: out of 128 priced US health stocks, 64 rose and 43 fell. Notable movers include Bristol-Myers Squibb Co (BMY) at USD 61.49, up 4.01%, Biogen Inc (BIIB) at USD 233.37, up 3.39%, and Enveric Biosciences Inc (ENVB) at USD 1.40, down 3.45%. Typical hold times on Pluang range from 14 to 111 days among these stocks.
Alignment Health Plan introduced Central Health Harmony, a new Medicare Advantage plan starting January 1, 2027, targeting Asian American seniors in Los Angeles and Orange counties. The plan offers access to over 600 physicians who speak Chinese, Kor...
NVIDIA and Cisco have introduced Ultra-Dense Small Form Factor Pluggable (USFP), a new optical module supporting 400Gb/s per lane, enabling up to 12.8Tb/s capacity for AI data centers. This technology doubles bandwidth per lane and increases power ef...
Hasbro announced the fourth annual Women Innovators of Play Design Challenge, accepting submissions from October 15 to November 20, 2026. The program now includes year-round in-person networking events alongside the design competition, aiming to conn...
Micas Networks introduced three new 102.4 Tbps open Ethernet switch platforms based on Broadcom Tomahawk 6 technology, designed to enhance AI factory networks. The portfolio includes air-cooled 800G, liquid-cooled 1.6T, and co-packaged optics (CPO) s...
Ferrari N.V. has repurchased 43,000 of its common shares on Euronext Milan as part of the third tranche of its multi-year €3.5 billion share buyback program announced in 2025. The recent purchases, totaling nearly €14.8 million, are part of a broader...
